CMOTEC_B: Animal Care sales drove improved results, but continued financing is required for growth

About this update from Scandinavian Chemotech Ab Class B

Revenue and operating results improved year-over-year, driven by Animal Care sales and cost control. Ongoing regulatory progress in Human Care and a successful rights issue support future growth, though further financing is needed.Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

View stock analysis, news, and events for Scandinavian Chemotech Ab Class B